Accessibility Menu
 
AstraZeneca Plc logo

AstraZeneca Plc

(LSE) AZN

Current Price$13512.00
Market Cap$20.95T
Since IPO (1993)+6,017%
5 Year+75%
1 Year+27%
1 Month-10%

AstraZeneca Plc Financials at a Glance

Market Cap

$20.95T

Revenue (TTM)

$60.83B

Net Income (TTM)

$10.45B

EPS (TTM)

$496.37

P/E Ratio

27.03

Dividend

$236.20

Beta (Volatility)

-0.04 (Low)

Price

$13512.00

Volume

1,404,047

Open

$13810.00

Previous Close

$13512.00

Daily Range

$13512.00 - $13810.00

52-Week Range

$9651.00 - $15730.00

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About AstraZeneca Plc

Industry

Pharmaceuticals

Employees

96,100

CEO

Pascal Soriot, MBA, DVM

Headquarters

Cambridge, CB2 0AA, GB

AZN Financials

Key Financial Metrics (TTM)

Gross Margin

80%

Operating Margin

24%

Net Income Margin

17%

Return on Equity

23%

Return on Capital

18%

Return on Assets

9%

Earnings Yield

3.70%

Dividend Yield

1.75%

Payout Ratio

46.98%

Stock Overview

Market Cap

$20.95T

Shares Outstanding

1.55B

Volume

1.40M

Avg. Volume

2.63M

Financials (TTM)

Gross Profit

$48.11B

Operating Income

$13.74B

EBITDA

$19.83B

Operating Cash Flow

$14.57B

Capital Expenditure

$5.91B

Free Cash Flow

$8.67B

Cash & ST Invst.

$5.74B

Total Debt

$29.62B

AstraZeneca Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$15.29B

+9.5%

Gross Profit

$12.61B

+18.2%

Gross Margin

82.48%

N/A

Market Cap

$20.95T

N/A

Market Cap/Employee

$222.21M

N/A

Employees

94,300

N/A

Net Income

$3.08B

+2.8%

EBITDA

$5.67B

+9.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$26.24B

-1.4%

Accounts Receivable

$14.11B

-5.0%

Inventory

$6.57B

+11.4%

Long Term Debt

$25.96B

-6.9%

Short Term Debt

$7.96B

+133.7%

Return on Assets

9.17%

N/A

Return on Invested Capital

17.57%

N/A

Free Cash Flow

$1.82B

-44.5%

Operating Cash Flow

$3.36B

-9.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GSK.LGSK plc
$1901.00-1.43%
HLN.LHaleon plc
$344.10+1.21%
SN.LSmith & Nephew plc
$1147.00+0.88%
CTEC.LConvaTec Group Plc
$210.00-0.38%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%

Questions About AZN

What is the current price of AstraZeneca Plc?

AstraZeneca Plc is trading at GBX 13,512.00 per share.

What is the 52-week range for AstraZeneca Plc?

Over the past 52 weeks, AstraZeneca Plc has traded between GBX 9,651.00 and GBX 15,730.00.

How much debt does AstraZeneca Plc have?

As of the most recent reporting period, AstraZeneca Plc reported total debt of $25.72B.

How much cash does AstraZeneca Plc have on hand?

AstraZeneca Plc reported $5.73B in cash and cash equivalents in its most recent financial results.

What is AstraZeneca Plc’s dividend yield?

AstraZeneca Plc currently has a dividend yield of 1.75%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.